Christopher Carroll (C Carroll, Chris Carroll)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 22

Top Venues

RMD open

PharmacoEconomics

PloS one

PLoS neglected tropical diseases

University of Sheffield

University of Sheffield (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sheffield Feb 01 2014

United Kingdom

Reader in Systematic Review and Evidence Synthesis :: School of Health and Related Research (ScHARR)

University of Sheffield Feb 01 2011 - Jan 31 2014

United Kingdom

Senior Lecturer in HTA :: School of Health and Related Research (ScHARR)

University of Sheffield Sep 01 2007 - Jan 31 2011

United Kingdom

Research Fellow in Systematic Review :: School of Health and Related Research (ScHARR)

University of Sheffield Aug 31 2005 - Aug 31 2007

United Kingdom

Research Associate :: School of Health and Related Research (ScHARR)

Education History

University of Sheffield Oct 01 2002 - Sep 30 2003

United Kingdom

MSC :: Information Science

University of Cambridge Oct 01 1995 - Sep 30 1998

United Kingdom

PHD :: History

Publications

Joanna Leaviss, Christopher Carroll, Munira Essat, Danielle A van der Windt, Matthew J Grainge, Timothy R Card, Richard Riley, Abhishek Abhishek, null null
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review. RMD open 10 (1) (2024)
Christopher Carroll, Burak Kundakci, Amber Muhinyi, Anastasios Bastounis, Katherine Jones, Anthea Sutton, Steve Goodacre, Carl Marincowitz, Andrew Booth
Scoping review of the effectiveness of 10 high-impact initiatives (HIIs) for recovering urgent and emergency care services. BMJ open quality 13 (3) (2024)
Joanna Leaviss, Christopher Carroll, Munira Essat, Danielle A van der Windt, Matthew J Grainge, Timothy R Card, Richard Riley, Abhishek Abhishek, null null
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review. RMD open 10 (1) (2024)
Joanna Leaviss, Christopher Carroll, Munira Essat, Danielle A van der Windt, Matthew J Grainge, Timothy R Card, Richard Riley, Abhishek Abhishek, null null
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review. RMD open 10 (1) (2024)
Simon Dixon, Kirti Tyagi, Malkeet Singh, Sitanshu Sekhar Kar, Bhavani Shankara Bagepally, Shankar Prinja, Andrew Booth, Christopher Carroll, Aamir Sohail, Abha Mehndiratta
Development of a competency framework for health technology assessment in India. BMJ evidence-based medicine (2024)
Joanna Leaviss, Christopher Carroll, Munira Essat, Danielle A van der Windt, Matthew J Grainge, Timothy R Card, Richard Riley, Abhishek Abhishek, null null
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review. RMD open 10 (1) (2024)
Joanna Leaviss, Christopher Carroll, Munira Essat, Danielle A van der Windt, Matthew J Grainge, Timothy R Card, Richard Riley, Abhishek Abhishek, null null
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review. RMD open 10 (1) (2024)
Christopher Carroll, Andrew Booth, Diana Castelblanco Cuevas
What matters to adolescents with obesity, and their caregivers, when considering bariatric surgery or weight loss devices? A qualitative evidence synthesis. Obesity reviews : an official journal of the International Association for the Study of Obesity (2023)
Christopher Carroll, Katie Sworn, Andrew Booth, Aki Tsuchiya, Michelle Maden, Megumi Rosenberg
Equity in healthcare access and service coverage for older people: a scoping review of the conceptual literature. Integrated healthcare journal 4 (1) (2022)
Christopher Carroll, Katie Sworn, Andrew Booth, Hector Pardo-Hernandez
Stakeholder views of services for children and adolescents with obesity: Mega-ethnography of qualitative syntheses. Obesity (Silver Spring, Md.) 30 (11) (2022)
Fiona Campbell, Andrew Booth, Christopher Carroll, Andrew C K Lee, Clare Relton
Qualitative evidence syntheses of attitudes and preferences to inform guidelines on infant feeding in the context of Ebola Virus Disease (EVD) transmission risk. PLoS neglected tropical diseases 16 (3) (2022)
Kayode Philip Fadahunsi, Siobhan O'Connor, James Tosin Akinlua, Petra A Wark, Joseph Gallagher, Christopher Carroll, Josip Car, Azeem Majeed, John O'Donoghue
Information Quality Frameworks for Digital Health Technologies: Systematic Review. Journal of medical Internet research 23 (5) (2021)
Heather Burnett, Helena Emich, Christopher Carroll, Naomi Stapleton, Parthiv Mahadevia, Tracy Li
Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review. PloS one 16 (3) (2021)
Christopher Carroll, Andrew Booth, Fiona Campbell, Clare Relton
Qualitative evidence synthesis of values and preferences to inform infant feeding in the context of non-HIV transmission risk. PloS one 15 (12) (2020)
Paul Tappenden, Christopher Carroll, Jean Hamilton, Eva Kaltenthaler, Ruth Wong, Jonathan Wadsley, Laura Moss, Sabapathy P Balasubramanian
Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model. Health technology assessment (Winchester, England) 23 (8) (2020)
Sarah Davis, Rachid Rafia, Christopher Carroll, Jean Hamilton, Munira Essat
Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 37 (6) (2020)
Christopher Carroll, Andrew Booth, Fiona Campbell, Clare Relton
What are the implications of Zika Virus for infant feeding? A synthesis of qualitative evidence concerning Congenital Zika Syndrome (CZS) and comparable conditions. PLoS neglected tropical diseases 14 (10) (2020)
Christopher Carroll, R Dickson, A Boland, R Houten, M Walton
Decision-making by the NICE Interventional Procedures Advisory Committee. The British journal of surgery 106 (13) (2019)
Christopher Carroll, Faizan Mahmood
Risk of bias and the reporting of surgeons' experience in randomized controlled trials of total hip and total knee arthroplasty: A systematic review. Journal of evaluation in clinical practice 25 (2) (2018)
Christopher Carroll, Eva Kaltenthaler
Nature and reporting characteristics of UK health technology assessment systematic reviews. BMC medical research methodology 18 (1) (2018)
Christopher Carroll, Paul Tappenden, Rachid Rafia, Jean Hamilton, Duncan Chambers, Mark Clowes, Paul Durrington, Nadeem Qureshi, Anthony S Wierzbicki
Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 35 (5) (2017)
Christopher Carroll, Paul Tappenden, Rachid Rafia, Jean Hamilton, Duncan Chambers, Mark Clowes, Paul Durrington, Nadeem Qureshi, Anthony S Wierzbicki
Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics (2016)

Christopher Carroll.css-eqlu8i{font-size:small;padding-left:4px;} (C Carroll, Chris Carroll)

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher Carroll (C Carroll, Chris Carroll)